{"record":{"code":"W-00132","indicator":"Debarred / sanctioned abroad × US SEC issuer","class_b":false,"subject":"GSK · SUB~ · BR · GLAXO-SMITHKLINE BIOLOGICALS MANUFACTURING S.A","buyer":"","amount":130286959.95347999,"currency":null,"records":7,"found":"2026-10-04","refs":["ocds-ye9ov3-33781055000135_2025_1761","ocds-ye9ov3-33781055000135_2025_260","ocds-ye9ov3-33781055000135_2025_855","ocds-914jxj-25444506002052024","ocds-914jxj-25444506001122025","ocds-914jxj-25444506003452025","ocds-914jxj-25444507002342025"],"id":"W-00132","html":"https://worldwide-corruption.com/record/brazil/findings/fcpa-pattern/W-00132/","json":"https://worldwide-corruption.com/record/brazil/findings/fcpa-pattern/W-00132/index.json","why":"Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'GLAXOSMITHKLINE BIOLOGICALS ~0.76' «GLAXO-SMITHKLINE BIOLOGICALS MANUFACTURING S.A» ↔ SEC GSK (CIK 1131399, GSK plc): 7 non-competitive contracts at the buyer «FUNDACAO OSWALDO CRUZ», 723,816,444 BRL (≈ $130,286,960); method direct (tipoInstrumentoConvocatorioCodigo: 3; tipoInstrumentoConvocatorioNome: Ato que autoriza a Contratação Direta; modalidadeId: 8; modalidadeNome: Dispensa; modoDisputaId: 5; modoDisputaNom; OCID ocds-ye9ov3-33781055000135_2025_1761, ocds-ye9ov3-33781055000135_2025_260, ocds-ye9ov3-33781055000135_2025_855, ocds-914jxj-25444506002052024, ocds-914jxj-25444506001122025, ocds-914jxj-25444506003452025, ocds-914jxj-25444507002342025.","facts":[["Company / subject","GSK · SUB~ · BR · GLAXO-SMITHKLINE BIOLOGICALS MANUFACTURING S.A",null],["Indicator","Debarred / sanctioned abroad × US SEC issuer",null],["Amount","130,286,960",null],["Records behind the indicator","7",null],["Found","4 October 2026",null],["Code","W-00132",null],["Reference","ocds-ye9ov3-33781055000135_2025_1761",null],["Reference","ocds-ye9ov3-33781055000135_2025_260",null],["Reference","ocds-ye9ov3-33781055000135_2025_855",null],["Reference","ocds-914jxj-25444506002052024",null],["Reference","ocds-914jxj-25444506001122025",null],["Reference","ocds-914jxj-25444506003452025",null],["Reference","ocds-914jxj-25444507002342025",null]],"summary":"looks like a subsidiary 'GLAXOSMITHKLINE BIOLOGICALS ~0.76' «GLAXO-SMITHKLINE BIOLOGICALS MANUFACTURING S.A» ↔ SEC GSK (CIK 1131399, GSK plc): 7 non-competitive contracts at the buyer «FUNDACAO OSWALDO CRUZ», 723,816,444 BRL (≈ $130,286,960); method direct (tipoInstrumentoConvocatorioCodigo: 3; tipoInstrumentoConvocatorioNome: Ato que autoriza a Contratação Direta; modalidadeId: 8; modalidadeNome: Dispensa; modoDisputaId: 5; modoDisputaNom; OCID ocds-ye9ov3-33781055000135_2025_1761, ocds-ye9ov3-33781055000135_2025_260, ocds-ye9ov3-33781055000135_2025_855, ocds-914jxj-25444506002052024, ocds-914jxj-25444506001122025, ocds-914jxj-25444506003452025, ocds-914jxj-25444507002342025","entity":"58f99eaf"},"about":"Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.","evidence":[],"row":{"country":"Brazil","iso2":"BR","part":"Findings","indicator":"Debarred / sanctioned abroad × US SEC issuer","about":"Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.","findings":1312,"new_today":0,"on_pages":1312,"full_list":[],"html":"https://worldwide-corruption.com/database/brazil/findings/fcpa-pattern/","json":"https://worldwide-corruption.com/database/brazil/findings/fcpa-pattern/index.json"},"other_records_of_this_company":[],"html":"https://worldwide-corruption.com/record/brazil/findings/fcpa-pattern/W-00132/","json":"https://worldwide-corruption.com/record/brazil/findings/fcpa-pattern/W-00132/index.json"}